by Susan Brinkmann, OCDS
Staff Writer
(June 26, 2008) One of the world’s largest pharmaceutical research companies, Pfizer, has announced plans to fund a new adult stem-cell treatment that could treat diabetes-induced retinal damage, a leading cause of blindness.
